Neoadjuvant Chemotherapy Combined With Sintilimab and Bevacizumab for TNBC (NEOTORCH-BREAST07)
Clinical trial NCT07351487 · RECRUITING
Trial details
- NCT number
- NCT07351487
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-25
- Primary completion
- 2028-09-25
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.